The biotechnology, chemical, and pharmaceuticals (BCP) technology groups at the U.S. Patent and Trademark Office will hold their next quarterly customer partnership meeting on March 3, 2009 at the USPTO's Madison Auditorium, 600 Dulany Street, Alexandria, VA.
The schedule of topics for discussion include (all times Eastern):
Morning Session
• Greetings and Overview (10:00 - 10:15 AM): John LeGuyader, Remy Yucel, Andrew Wang, Directors, Technology Center 1600
• Patent Term Extension (10:15 - 11:00 AM): Mary Till, Office of Patent Legal Administration
• Chemical Unity of Invention Practice (11:00 - 11:45 AM): Julie Burke, QAS, TC 1600
• Break (11:45 -12:00 AM)
• 35 U.S.C. § 112, Paragraph 6 Training (12:00 - 12:45 PM): Jean Witz, QAS, TC 1600
• Lunch (12:00 - 1:15 PM)
• Patent Term Extension (10:15 - 11:00 AM): Mary Till, Office of Patent Legal Administration
• Chemical Unity of Invention Practice (11:00 - 11:45 AM): Julie Burke, QAS, TC 1600
• Break (11:45 -12:00 AM)
• 35 U.S.C. § 112, Paragraph 6 Training (12:00 - 12:45 PM): Jean Witz, QAS, TC 1600
• Lunch (12:00 - 1:15 PM)
Afternoon Session
• Topics in Viral Immunology (1:45 - 2:30 PM): Bruce Campell, SPE, Art Unit 1648
• Break (2:30 - 2:45 PM)
• Transgenic Plants (2:45 - 3:30 PM): Anne Marie Grunberg, SPE, Art Unit 1638/1661
• Update on Gene Therapy and Transgenics (3:30 - 4:15 PM): Peter Paras, SPE, Art Unit 1632
• Closing Remarks/Discussion (4:15 – 4:30 PM): John LeGuyader, Remy Yucel, Andrew Wang, Directors, Technology Center 1600
• Break (2:30 - 2:45 PM)
• Transgenic Plants (2:45 - 3:30 PM): Anne Marie Grunberg, SPE, Art Unit 1638/1661
• Update on Gene Therapy and Transgenics (3:30 - 4:15 PM): Peter Paras, SPE, Art Unit 1632
• Closing Remarks/Discussion (4:15 – 4:30 PM): John LeGuyader, Remy Yucel, Andrew Wang, Directors, Technology Center 1600
Comments